Identification of Promoter Region Methylation Patterns of MGMT , CDKN2A , GSTP1 , and THBS1 Genes in Intracranial Meningioma Patients
- 1 May 2012
- journal article
- research article
- Published by SAGE Publications in Genetic Testing and Molecular Biomarkers
- Vol. 16 (5) , 335-340
Abstract
Background: Cytogenetic, molecular and epigenetic changes are all known to take place in the pathogenesis of meningiomas. In this study, we aimed at investing methylation of MGMT (DNA repair), CDKN2A (cell cycle control), GSTP1 (detoxification), and THBS1 (angiogenesis inhibitor) genes, which are known to be unmethylated in normal tissue, in meningioma samples. Materials and Methods: Methylation specific polymerase chain reaction was used to study promoter regions methylation of genes in 36 patient samples. Results: Methylation in promoter regions of MGMT, CDKN2A, GSTP1, and THBS1 genes were found in 11.1%, 8.3%, 2.8%, and 0% of the cases, respectively. About 19.4% of cases revealed promoter methylation of at least a single gene, whereas only 2.8% of cases revealed methylation of more than one gene. Based on their World Health Organization 2007 grade; 6.3% of grade I cases, 35.3% of grade II cases, and 33.3% of grade III cases showed hypermethylation in the promoter regions of the genes studied. No statistically significant relation was found between promoter zone methylation and factors such as age, sex, histopathology, grade, or recurrence. Conclusions: Further research on promoter zone methylation will help expose the methylation profile and pathogenesis of meningiomas, which will consequently guide to a deeper understanding of the pathogenesis of the disease, thus ensuring a better understanding of the prognosis and considering novel treatment options.Keywords
This publication has 23 references indexed in Scilit:
- Methylation status of MGMT gene promoter in meningiomasCancer Genetics and Cytogenetics, 2008
- Epigenetics in CancerNew England Journal of Medicine, 2008
- Genome–epigenome interactions in cancerHuman Molecular Genetics, 2007
- DNA methylation of multiple promoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22qActa Neuropathologica, 2004
- CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter futureOncogene, 2002
- Alterations of the Tumor Suppressor Genes CDKN2A (p16), p14, CDKN2B (p15), and CDKN2C (p18) in Atypical and Anaplastic MeningiomasThe American Journal of Pathology, 2001
- Epigenetic lesions causing genetic lesions in human cancerEuropean Journal of Cancer, 2000
- Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomasHuman Molecular Genetics, 2000
- Allelic loss at 1 p is associated with tumor progression of meningiomasGenes, Chromosomes and Cancer, 1994
- Deletion mapping of a locus on human chromosome 22 involved in the oncogenesis of meningioma.Proceedings of the National Academy of Sciences, 1987